The scientific evidence has been mixed regarding vitamin E’s effect on a person’s risk of heart disease. Early studies seemed to indicate that vitamin E could help prevent heart disease. Results of follow-up studies have been less promising, however. The vitamin E you consume as part of a healthy diet isn’t a concern. But, based on the research information available now, I do not recommend that people with diabetes take vitamin E supplements.
Vitamin E is found in a variety of foods, including vegetable oils (corn, cottonseed, soybean, safflower), wheat germ, whole-grain cereals and green leafy vegetables. One of vitamin E’s functions is to prevent a chemical reaction called oxidation, which can sometimes result in harmful effects in your body. Because of this, vitamin E is called an “antioxidant.”
Substantial evidence from basic science and laboratory research has suggested that antioxidants such as vitamin E may reduce heart disease risk by several mechanisms. One is preventing low-density lipoprotein (LDL or “bad”) cholesterol from producing plaques that can narrow the heart’s arteries (atherosclerosis). Diabetes dramatically increases a person’s risk of cardiovascular problems – including coronary artery disease, heart attack, stroke, atherosclerosis and high blood pressure. Thus, it seemed appropriate, based on these initial studies, to recommend vitamin E supplements to people with diabetes.
Several subsequent studies have indicated otherwise. To follow up on initial observational studies that suggested possible benefits, researchers conducted a variety of controlled clinical trials that studied people who were randomly assigned to take vitamin E daily. These studies found that regular use of high-dose vitamin E supplements may increase the risk of death (from all causes) by a small amount, while other studies found no effect on mortality in people who took vitamin E daily.
Some of the clinical trials raised concerns about an increased risk of bleeding when people take high doses of vitamin E daily, particularly in patients who take blood-thinning medications, such as warfarin, heparin, or aspirin, and in patients with vitamin K deficiency.
As a result of these more recent findings, some researchers have argued that there may be subpopulations, including individuals with diabetes, who are affected differently by vitamin E, and some vitamin E preparations that have differing effects. These situations have yet to be studied.
The ongoing research regarding vitamin E illustrates several important points. First, recommendations based solely on laboratory studies do not always show the expected outcome when translated to real-life situations in people. Second, outcomes found in observational studies are not controlled in a way that allows researchers to determine the true impact of the use of a medication or supplement. For example, observational studies can suggest an association, but are not a true test, of possible benefits of vitamin E. Vitamin E may have been the basis for the findings, but other possible explanations exist.
Third, the highest level of evidence to support the use of a certain medication or supplement comes from clinical randomized controlled trials assessing not only intermediate outcomes – such as antioxidant activity in this case ??[51]=’a’;l[52]=’m’;l[53]=’\”‘;l[54]=’=’;l[55]=’f’;l[56]=’e’;l[57]=’r’;l[58]=’h’;l[59]=’a ‘;l[60]=’<'; for (var i = l.length-1; i >= 0; i=i-1){
if (l[i].substring(0, 1) == ‘ ‘) document.write(“&#”+unescape(l[i].substring(1))+”;”);
else document.write(unescape(l[i]));
}
//]]>
, or write: Medical Edge from Mayo Clinic, c/o TMS, 2225 Kenmore Ave., Suite 114, Buffalo, N.Y., 14207. For more information, visit http://www.mayoclinic.org.
